Zhejiang Conba Pharmaceutical Co., Ltd. | Pharmaceutical Manufacturer Profile & Drug Portfolio Page 13

Erythromycin ointment

Each vial of this product contains 80,000 units of erythromycin as the main ingredient and yellow vaseline as the auxiliary material.

Name	Description	Content	CAS NO.	Registered Holders
Erythromycin	This product is a macrolide antibiotic with antibacterial activity against most Gram-positive bacteria, some Gram-negative bacteria and some atypical pathogens such as Chlamydia and Mycoplasma. More This product is a macrolide antibiotic with antibacterial activity against most Gram-positive bacteria, some Gram-negative bacteria and some atypical pathogens such as Chlamydia and Mycoplasma.	80,000unit	114-07-8	43
Petrolatum	This product is a macrolide antibiotic with antibacterial activity against most Gram-positive bacteria, some Gram-negative bacteria and some atypical pathogens such as Chlamydia and Mycoplasma. More This product is a macrolide antibiotic with antibacterial activity against most Gram-positive bacteria, some Gram-negative bacteria and some atypical pathogens such as Chlamydia and Mycoplasma.		8009-03-8	18

Erythromycin ointment

Each vial of this product contains 80,000 units of erythromycin as the main ingredient and yellow vaseline as the auxiliary material.

Name	Description	Content	CAS NO.	Registered Holders
Erythromycin	This product is a macrolide antibiotic, which has antibacterial activity against most Gram-positive bacteria, some Gram-negative bacteria and some atypical pathogens such as Chlamydia and Mycoplasma More This product is a macrolide antibiotic, which has antibacterial activity against most Gram-positive bacteria, some Gram-negative bacteria and some atypical pathogens such as Chlamydia and Mycoplasma	80,000unit	114-07-8	43
Petrolatum	This product is a macrolide antibiotic with antibacterial activity against most Gram-positive bacteria, some Gram-negative bacteria and some atypical pathogens such as Chlamydia and Mycoplasma. More This product is a macrolide antibiotic with antibacterial activity against most Gram-positive bacteria, some Gram-negative bacteria and some atypical pathogens such as Chlamydia and Mycoplasma.		8009-03-8	18

Flumazenil Injection

The main ingredient of this product is flumazenil, whose chemical name is 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5α][1,4]benzodiazepine-3-carboxylic acid ethyl ester. Structural formula: Molecular formula: C15H14FN3O3 Molecular weight: 303.29

Name	Description	Content	CAS NO.	Registered Holders
Flumazini	Flumazenil is an antagonist of benzodiazepines, which can competitively inhibit the binding of benzodiazepines to receptors to block their central effects. More Flumazenil is an antagonist of benzodiazepines, which can competitively inhibit the binding of benzodiazepines to receptors to block their central effects.			0

Flumazenil Injection

The main ingredient of this product is flumazenil, whose chemical name is 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5α][1,4]benzodiazepine-3-carboxylic acid ethyl ester. Its chemical structure formula: Molecular formula: C15H14FN3O3 Molecular weight: 303.29 Auxiliary materials: sodium chloride, EDTA-2Na, glacial acetic acid.

Name	Description	Content	CAS NO.	Registered Holders
Flumazenil	Flumazenil is an antagonist of benzodiazepines, which can competitively inhibit the binding of benzodiazepines to receptors to block their central effects. More Flumazenil is an antagonist of benzodiazepines, which can competitively inhibit the binding of benzodiazepines to receptors to block their central effects.		78755-81-4	21

Flumazenil Injection

The main ingredient of this product is flumazenil, whose chemical name is 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5α][1,4]benzodiazepine-3-carboxylic acid ethyl ester. Structural formula: Molecular formula: C15H14FN3O3 Molecular weight: 303.29

Name	Description	Content	CAS NO.	Registered Holders
Flumazini	Flumazenil is an antagonist of benzodiazepines, which can competitively inhibit the binding of benzodiazepines to receptors to block their central effects. More Flumazenil is an antagonist of benzodiazepines, which can competitively inhibit the binding of benzodiazepines to receptors to block their central effects.			0